Tajuk
Brolucizumab (RTH258) For Neovascular Age-Related Macular Degeneration (NAMD)
Tahun
2019-016-S
Lampiran-lampiran
2019-016-S Brolucizumab (RTH258) For Neovascular Age-Related Macular Degeneration (NAMD).pdf